Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries.

Nafees B, Setyawan J, Lloyd A, Ali S, Hearn S, Sasane R, Sonuga-Barke E, Hodgkins P.

Eur Child Adolesc Psychiatry. 2014 Dec;23(12):1189-200. doi: 10.1007/s00787-013-0515-6. Epub 2014 Jan 18.

2.

Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway.

Glenngård AH, Hjelmgren J, Thomsen PH, Tvedten T.

Nord J Psychiatry. 2013 Oct;67(5):351-9. doi: 10.3109/08039488.2012.748825. Epub 2012 Dec 17.

PMID:
23245636
3.

Assessment of parents' preferences for the treatment of school-age children with ADHD: a discrete choice experiment.

Fegert JM, Slawik L, Wermelskirchen D, Nübling M, Mühlbacher A.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):245-52. doi: 10.1586/erp.11.22. Review.

PMID:
21671692
4.

Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences.

Lloyd A, Hodgkins P, Dewilde S, Sasané R, Falconer S, Sonuga Barke E.

Int J Technol Assess Health Care. 2011 Jul;27(3):215-23. doi: 10.1017/S0266462311000249. Epub 2011 Jul 8.

PMID:
21736859
5.

Physician perceptions of the use of medications for attention deficit hyperactivity disorder.

Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.

J Manag Care Pharm. 2003 Sep-Oct;9(5):416-23.

6.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
7.

A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD.

Waschbusch DA, Cunningham CE, Pelham WE, Rimas HL, Greiner AR, Gnagy EM, Waxmonsky J, Fabiano GA, Robb JA, Burrows-Maclean L, Scime M, Hoffman MT.

J Clin Child Adolesc Psychol. 2011;40(4):546-61. doi: 10.1080/15374416.2011.581617.

8.

Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):226-37. doi: 10.1089/cap.2011.0090. Epub 2012 Apr 26.

9.

Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment.

Mühlbacher AC, Rudolph I, Lincke HJ, Nübling M.

BMC Health Serv Res. 2009 Aug 13;9:149. doi: 10.1186/1472-6963-9-149.

10.
11.

Investigating ADHD treatment trajectories: listening to families' stories about medication use.

Leslie LK, Plemmons D, Monn AR, Palinkas LA.

J Dev Behav Pediatr. 2007 Jun;28(3):179-88.

PMID:
17565284
12.

Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.

Hodgkins P, Swinburn P, Solomon D, Yen L, Dewilde S, Lloyd A.

Patient. 2012;5(1):33-44. doi: 10.2165/11595390-000000000-00000.

PMID:
22077619
14.

Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.

van der Kolk A, Bouwmans CA, Schawo SJ, Buitelaar JK, van Agthoven M, Hakkaart-van Roijen L.

J Ment Health Policy Econ. 2014 Sep;17(3):119-29.

PMID:
25543115
15.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

16.

Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder.

Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC.

J Dev Behav Pediatr. 2003 Jun;24(3):155-62.

PMID:
12806227
17.

Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.

Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S.

Med Decis Making. 2005 Jan-Feb;25(1):56-70.

PMID:
15673582
18.

Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder.

Ahmed R, McCaffery KJ, Aslani P.

J Child Adolesc Psychopharmacol. 2013 Apr;23(3):163-78. doi: 10.1089/cap.2012.0087. Epub 2013 Apr 6. Review.

PMID:
23560602
19.

Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community.

dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R.

J Behav Health Serv Res. 2006 Oct;33(4):423-30.

PMID:
17078011
20.

Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.

Johnston C, Seipp C, Hommersen P, Hoza B, Fine S.

Child Care Health Dev. 2005 Nov;31(6):669-77.

PMID:
16207224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk